Dr. Stephen Z. Smith, M.D.
Dermatology (Dermatology Physician)
- Medicare participating
At a glance
- Medical school
- Johns Hopkins University School of Medicine (1971)
- Years since graduation
- 55
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 1,168
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1971Medical school: Johns Hopkins University School of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
KY license 17338 -
Dermatopathology Physician
KY license 17338 -
Procedural Dermatology Physician
KY license 17338
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Baptist Health Louisville Louisville, KY
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,168
- Services billed
- 26,318
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 14,000 | 51 |
| Destruction of precancer skin growth, 2-14 growths | 7,476 | 771 |
| Pathology examination of tissue using a microscope, intermediate complexity | 6,755 | 1,396 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 2,109 | 324 |
| Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, more than 2.0 cm | 1,921 | 1,223 |
| Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | 1,590 | 931 |
| Shaving of skin growth of scalp, neck, hands, feet, or genitals, more than 2.0 cm | 1,552 | 977 |
| Destruction of precancer skin growth, 15 or more growths | 1,143 | 799 |
| Shaving of skin growth of body, arms, or legs, more than 2.0 cm | 1,073 | 678 |
| Destruction of precancer skin growth, 1 growth | 969 | 772 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Mupirocin Other prescribers in Louisville, KY | 524 |
| Mometasone Furoate Other prescribers in Louisville, KY | 264 |
| Ciclopirox Other prescribers in Louisville, KY | 151 |
| Doxycycline Hyclate Other prescribers in Louisville, KY | 126 |
| Cephalexin Other prescribers in Louisville, KY | 113 |
| Triamcinolone Acetonide Other prescribers in Louisville, KY | 108 |
| Metronidazole Other prescribers in Louisville, KY | 96 |
| Betamethasone Dipropionate Other prescribers in Louisville, KY | 87 |
| Ciclopirox (ciclopirox olamine) | 85 |
| Clobetasol Propionate Other prescribers in Louisville, KY | 76 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 10 companies reported 48 payments worth $1,032 in total to this clinician.
| UCB, Inc. | $489 |
|---|---|
| Janssen Biotech, Inc. | $195 |
| Arcutis Biotherapeutics, Inc. | $127 |
| AbbVie Inc. | $66.54 |
| Organon LLC | $62.73 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.16 |
| Biofrontera Inc. | $19.45 |
| Pfizer Inc. | $19.08 |
| Food and Beverage | $984 |
|---|---|
| Education | $47.99 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. May 19, 2025 | Education TREMFYA · Immunology · in-kind | $47.99 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.